RU2021113343A - RADIOPHARMACEUTICALS TARGETING GRPR AND THEIR APPLICATIONS - Google Patents
RADIOPHARMACEUTICALS TARGETING GRPR AND THEIR APPLICATIONS Download PDFInfo
- Publication number
- RU2021113343A RU2021113343A RU2021113343A RU2021113343A RU2021113343A RU 2021113343 A RU2021113343 A RU 2021113343A RU 2021113343 A RU2021113343 A RU 2021113343A RU 2021113343 A RU2021113343 A RU 2021113343A RU 2021113343 A RU2021113343 A RU 2021113343A
- Authority
- RU
- Russia
- Prior art keywords
- composition according
- pharmaceutical composition
- grpr
- alkyl
- ala
- Prior art date
Links
- 101700014619 GRPR Proteins 0.000 title claims 7
- 239000012217 radiopharmaceutical Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- 230000003042 antagnostic Effects 0.000 claims 4
- 239000005557 antagonist Substances 0.000 claims 4
- 239000004094 surface-active agent Substances 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 3
- 238000003384 imaging method Methods 0.000 claims 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 239000002184 metal Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 230000002285 radioactive Effects 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- OCLLVJCYGMCLJG-CYBMUJFWSA-N (2R)-2-azaniumyl-2-naphthalen-1-ylpropanoate Chemical compound C1=CC=C2C([C@@](N)(C(O)=O)C)=CC=CC2=C1 OCLLVJCYGMCLJG-CYBMUJFWSA-N 0.000 claims 1
- FQRURPFZTFUXEZ-MRVPVSSYSA-N (2S)-2,3,3,3-tetrafluoro-2-(N-fluoroanilino)propanoic acid Chemical compound OC(=O)[C@](F)(C(F)(F)F)N(F)C1=CC=CC=C1 FQRURPFZTFUXEZ-MRVPVSSYSA-N 0.000 claims 1
- WTOFYLAWDLQMBZ-UHFFFAOYSA-N 2-azaniumyl-3-thiophen-2-ylpropanoate Chemical compound OC(=O)C(N)CC1=CC=CS1 WTOFYLAWDLQMBZ-UHFFFAOYSA-N 0.000 claims 1
- UQTZMGFTRHFAAM-ZETCQYMHSA-N 3-Iodotyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(I)=C1 UQTZMGFTRHFAAM-ZETCQYMHSA-N 0.000 claims 1
- NIGWMJHCCYYCSF-UHFFFAOYSA-N 4-Chloro-3-phenyl-L-alanine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 claims 1
- BKVAAWMQOQLENB-UHFFFAOYSA-M CCCC(O)CCCCCCCCCCCCCC([O-])=O Chemical compound CCCC(O)CCCCCCCCCCCCCC([O-])=O BKVAAWMQOQLENB-UHFFFAOYSA-M 0.000 claims 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 1
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 claims 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 claims 1
- OFYAYGJCPXRNBL-LBPRGKRZSA-N NAPHTHALEN-2-YL-3-ALANINE Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CC=CC2=C1 OFYAYGJCPXRNBL-LBPRGKRZSA-N 0.000 claims 1
- 229940043230 Sarcosine Drugs 0.000 claims 1
- 108010077895 Sarcosine Proteins 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 150000008378 aryl ethers Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- -1 fatty acid ester Chemical class 0.000 claims 1
- 150000004665 fatty acids Chemical group 0.000 claims 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 claims 1
- 125000003827 glycol group Chemical group 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine zwitterion Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims 1
- 238000002603 single-photon emission computed tomography Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N β-Alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims 1
Claims (37)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18200246.9 | 2018-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2021113343A true RU2021113343A (en) | 2022-11-14 |
RU2798978C2 RU2798978C2 (en) | 2023-06-30 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014396468B2 (en) | Modified cyclopentapeptides and uses thereof | |
SA96160495B1 (en) | THE USE OF MANY COMPLEX SOMATOSTATIN PEPTIDES FOR BIOLOGICAL IMAGING OF TUMONOS AND TUMOR SPREAD UNDERTAKEN THE SOMATOSTATIN RECEPTOR | |
JP2017534676A5 (en) | ||
KR20220063214A (en) | GRPR antagonist radiolabeling method and kit thereof | |
ES2929507T3 (en) | Method for labeling a biological targeting molecule by conjugation with a suitable radioisotope for PET or SPECT imaging | |
JP2014500262A (en) | 177 lutetium labeled bombesin analog for radiotherapy | |
ES2764119T3 (en) | Radiolabelling method | |
RU2021113343A (en) | RADIOPHARMACEUTICALS TARGETING GRPR AND THEIR APPLICATIONS | |
EP3880691A1 (en) | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders | |
WO2011131731A1 (en) | Cyclopeptide derivatives and uses thereof | |
JPWO2020074691A5 (en) | ||
CN117042812A (en) | CXCR 4-ligands and precursors thereof for diagnostic and therapeutic uses | |
JP7480132B2 (en) | Pharmaceutical Compositions Comprising Radiolabeled GPRP Antagonists and Surfactants - Patent application | |
RU2798978C2 (en) | Radiopharmaceuticals targeting grpr and their use | |
JPWO2021053040A5 (en) | ||
KR20040055784A (en) | Pacap compositions and methods for tumor imaging and therapy | |
KR20220034777A (en) | Compounds and Methods of Use | |
AR119975A1 (en) | METHODS FOR RADIOLABELING GRPR ANTAGONISTS AND THEIR KITS | |
KR20220118464A (en) | Compounds with improved pharmacokinetics for imaging and therapy of cancer | |
JPWO2021058549A5 (en) | ||
WO2024061483A1 (en) | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | |
TW202317206A (en) | A novel kit for radiopharmaceutical preparation of a radiometal labeled chelate-functionalized targeting conjugate |